PlainPill

CJC-1295 vs Tirzepatide for weight loss

Short answer: For weight loss, more users report improvement with CJC-1295 — 100% of 23 reports, versus 94% of 206 for Tirzepatide.

CJC-1295 has 0 meta-analyses and 1 randomized trials on PubMed; Tirzepatide has 214 and 132.

Based on 354 reports about CJC-1295 and 428 about Tirzepatide. Not medical advice.

CJC-1295
Peptide
Tirzepatide
Medication
Users say it helped57%helped131 reports · high confidence75%helped287 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchCResearch: LimitedAResearch: Strong
Meta-analyses / RCTs0 / 1214 / 132
Mainly used for
Weight loss
% reporting improvement
100% (23)94% (206)
Appetite
% reporting improvement
67% (3)84% (79)
Sleep
% reporting improvement
80% (44)56% (9)
Energy
% reporting improvement
91% (11)44% (32)
Performance
% reporting improvement
96% (23)83% (12)
Common side effectsflushing, allergic reaction, itching, increased appetitenausea, fatigue, anhedonia, constipation
Typical dose reportedNot listedNot listed
CJC-1295
What a user said
“Within a few weeks on cjc I noticed that I was more full, leaner, and sleep/recover was off the charts. My skin is crazy bright as well.”
Full CJC-1295 profile →
Tirzepatide
Latest review conclusion

This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.

Pharmacol Res, 2021 ↗
What a user said
“Tirzepatide works so well! Do some research in the r/peptides subreddit and the r/tirzepatide subreddit. It's the most effective thing I've ever seen for appetite suppressant.”
Full Tirzepatide profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate